Henning Keller, based in Germany, is currently a Business Unit Director Haemophilia DACH at Sobi - Swedish Orphan Biovitrum AB (publ). Henning Keller brings experience from previous roles at Novo Nordisk Pharma GmbH. Henning Keller holds a 1988 - 1998 Promotion, Diplom in Biologie: Zoologie, Biochemie, Mikrobiologie, Immunologie @ Johannes-Gutenberg-Unversität Mainz. With a robust skill set that includes Arzneimittelverkauf, Diabetes, Marktanalyse, Marketingstrategie, Product Launch and more. Henning Keller has 1 emails on RocketReach.
Looking for a different Henning Keller?
Find contact details for 700 million professionals.